<?xml version='1.0' encoding='UTF-8'?><!DOCTYPE collection SYSTEM 'BioC.dtd'>
<collection>
  <source>SourceData</source>
  <date>00000000</date>
  <key>sourcedata.key</key>
  <document>
    <id>5242375 Figure_1-A</id>
    <infon key="sourcedata_document">2405</infon>
    <infon key="doi">10.15252/embj.201695148</infon>
    <infon key="pmc_id">5242375</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>A HeLa cells expressing LAMP1-RFP were treated with vehicle alone (control) or LLOMe for 1 h to induce lysosome damage. Cells were fixed 2 h after washout, stained with p62 and galectin-3 (Gal3) antibodies, and analyzed by confocal microscopy.</text>
    </passage>
  </document>
  <document>
    <id>5242375 Figure_1-B</id>
    <infon key="sourcedata_document">2405</infon>
    <infon key="doi">10.15252/embj.201695148</infon>
    <infon key="pmc_id">5242375</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>B p97 translocates to ruptured lysosomes. Cells co-expressing LAMP1-RFP and GFP-p97 were treated as in (A) and stained with the pan-ubiquitin antibody FK2 (Ub). Percentage of cells showing recruitment of p97 in three independent experiments (mean &#177; SD).</text>
    </passage>
  </document>
  <document>
    <id>5242375 Figure_1-C</id>
    <infon key="sourcedata_document">2405</infon>
    <infon key="doi">10.15252/embj.201695148</infon>
    <infon key="pmc_id">5242375</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>C Immunodetection of endogenous p97 after LLOMe treatment as in (A). Percentage of cells showing recruitment of p97 in three independent experiments (mean &#177; SD).</text>
    </passage>
  </document>
  <document>
    <id>5242375 Figure_1-D</id>
    <infon key="sourcedata_document">2405</infon>
    <infon key="doi">10.15252/embj.201695148</infon>
    <infon key="pmc_id">5242375</infon>
    <infon key="figure">Figure 1-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D</infon>
    <passage>
      <offset>0</offset>
      <text>D Clearance of damaged lysosomes depends on p97. Cells were transfected with control (Ctrl) or p97 siRNA oligos, fixed at indicated time points after LLOMe washout and stained for endogenous Gal3. Quantification of the number of Gal3-positive vesicles per cell. Data represent mean &#177; SD of four independent experiments with &#8805;30 cells quantified per condition (one-sided Welch's unequal variances t-tests comparing the siCtrl with sip97).</text>
    </passage>
  </document>
  <document>
    <id>5242375 Figure_1-E</id>
    <infon key="sourcedata_document">2405</infon>
    <infon key="doi">10.15252/embj.201695148</infon>
    <infon key="pmc_id">5242375</infon>
    <infon key="figure">Figure 1-E</infon>
    <infon key="sourcedata_figure_dir">Figure_1-E</infon>
    <passage>
      <offset>0</offset>
      <text>E Cells were chased after LLOMe treatment for 12 h with vehicle alone (DMSO), bortezomib (Btz, 10 nM), NH4Cl (20 mM) or the p97 inhibitor NMS-873 (5 &#181;M), and Gal3 vesicles quantified. Data represent mean &#177; SEM of three independent experiments with &#8805;30 cells quantified per condition (one-sided Welch's t-tests).</text>
    </passage>
  </document>
  <document>
    <id>5242375 Figure_1-F</id>
    <infon key="sourcedata_document">2405</infon>
    <infon key="doi">10.15252/embj.201695148</infon>
    <infon key="pmc_id">5242375</infon>
    <infon key="figure">Figure 1-F</infon>
    <infon key="sourcedata_figure_dir">Figure_1-F</infon>
    <passage>
      <offset>0</offset>
      <text>F p97 is essential for cell survival after lysosome rupture. Cells were transfected with control (Ctrl), p97 or SEL1L siRNA oligos and treated with indicated concentrations of LLOMe for 12 h. Cell viability was measured using the MTS assay. Data represent mean &#177; SD of three independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>5242375 Figure_1-G</id>
    <infon key="sourcedata_document">2405</infon>
    <infon key="doi">10.15252/embj.201695148</infon>
    <infon key="pmc_id">5242375</infon>
    <infon key="figure">Figure 1-G</infon>
    <infon key="sourcedata_figure_dir">Figure_1-G</infon>
    <passage>
      <offset>0</offset>
      <text>G Taufibrils are endocytosed and induce lysosomal damage. Taufibrils were generated in vitro, fluorescently labelled by Dylight488 and fragmented by sonication (488-labelled tau). HeLa cells expressing mCherry-Gal3 were incubated with 300 nM taufibrils for 24 h. Arrows indicate compartments that contain 488-labelled tau and are positive for mCherry-Gal3 indicating lysosome rupture. Percentage of cells with Gal3-positive vesicles was quantified from three independent experiments (mean &#177; SD).</text>
    </passage>
  </document>
  <document>
    <id>5242375 Figure_1-H</id>
    <infon key="sourcedata_document">2405</infon>
    <infon key="doi">10.15252/embj.201695148</infon>
    <infon key="pmc_id">5242375</infon>
    <infon key="figure">Figure 1-H</infon>
    <infon key="sourcedata_figure_dir">Figure_1-H</infon>
    <passage>
      <offset>0</offset>
      <text>H Accumulation of tau-induced lysosomal damage upon p97 depletion. Cells transfected with control (Ctrl) or p97 siRNA oligos were treated as in (G). Percentage of cells with Gal3-positive vesicles was quantified from three independent experiments (mean &#177; SD). * = p &lt; 0.05; ** = p &lt; 0.01; *** = p &lt; 0.001. Scale bars, 10 &#181;m.</text>
    </passage>
  </document>
  <document>
    <id>5242375 Figure_2-A</id>
    <infon key="sourcedata_document">2405</infon>
    <infon key="doi">10.15252/embj.201695148</infon>
    <infon key="pmc_id">5242375</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Impaired clearance of damaged lysosomes in cells expressing a p97 disease-mutant. Wild-type and p97R155H/+MEFs were LLOMe-treated for 1 h and released for indicated times. Percentage of cells with Gal3-positive vesicles was quantified from three independent experiments (mean &#177; SD, Student's unpaired t-test). Scale bar, 25 &#181;m.</text>
    </passage>
  </document>
  <document>
    <id>5242375 Figure_2-B</id>
    <infon key="sourcedata_document">2405</infon>
    <infon key="doi">10.15252/embj.201695148</infon>
    <infon key="pmc_id">5242375</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Stable U2OS cell lines were doxycycline-induced to express myc-tagged p97 wild-type or disease-mutants as indicated. Induced parental cells served as control (U2OS -). Cells were treated with LLOMe for 1h and chased for indicated time before fixation. Percentage of cells with Gal3-positive vesicles was quantified from three independent experiments. Comparable expression levels were verified (see Figure EV2A).</text>
    </passage>
  </document>
  <document>
    <id>5242375 Figure_2-C</id>
    <infon key="sourcedata_document">2405</infon>
    <infon key="doi">10.15252/embj.201695148</infon>
    <infon key="pmc_id">5242375</infon>
    <infon key="figure">Figure 2-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C</infon>
    <passage>
      <offset>0</offset>
      <text>C Stable U2OS cell lines described in (B) were treated with LLOMe for 1 h and chased for indicated time. LC3 and GAPDH levels were analyzed by immunoblotting. Quantification is shown in Figure EV2B.</text>
    </passage>
  </document>
  <document>
    <id>5242375 Figure_2-D</id>
    <infon key="sourcedata_document">2405</infon>
    <infon key="doi">10.15252/embj.201695148</infon>
    <infon key="pmc_id">5242375</infon>
    <infon key="figure">Figure 2-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-D</infon>
    <passage>
      <offset>0</offset>
      <text>D Accumulation of damaged lysosomes in affected p97 patient skeletal muscle. Patient biopsies immunostained for Gal3 and caveolin-3 (Cav3). Quantification from 4 random 10X fields for each biopsy and means for controls and patients, respectively. Patients carry p97 mutations R155H (#1-3) or R93C for (#4). Patients #2 and #3 are cousins. Scale bar, 100 &#181;m.</text>
    </passage>
  </document>
  <document>
    <id>5242375 Figure_3-A-B</id>
    <infon key="sourcedata_document">2405</infon>
    <infon key="doi">10.15252/embj.201695148</infon>
    <infon key="pmc_id">5242375</infon>
    <infon key="figure">Figure 3-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>A Candidate screen for p97 cofactors involved in autophagy of damaged lysosomes. HeLa cells were transfected with indicated siRNA oligos and LLOMe-treated for 1 h. Cells were chased for 12 h, fixed and stained for Gal3. See Figure EV3 for depletion efficiency. B Quantification of the percentage of cells with more than three Gal3 vesicles per cell for each condition. This threshold was chosen so that less than 1% of untreated cells were considered positive. Data represent mean &#177; SEM of three independent experiments with &#8805;30 cells quantified per condition. * = p &lt; 0.05; ** = p &lt; 0.01; *** = p &lt; 0.001 (one-sided Welch's t-tests).</text>
    </passage>
  </document>
  <document>
    <id>5242375 Figure_3-C</id>
    <infon key="sourcedata_document">2405</infon>
    <infon key="doi">10.15252/embj.201695148</infon>
    <infon key="pmc_id">5242375</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>C YOD1, UBXD1 and PLAA are translocated along with p97 to ruptured lysosomes. Cells expressing indicated tagged proteins were LLOMe-treated for 1 h or with vehicle alone (control), fixed 2 h after washout, and stained for endogenous LAMP1 and, in the case of PLAA, with Alexa-488 conjugated anti-HA antibodies. See Figure EV3B for quantification.</text>
    </passage>
  </document>
  <document>
    <id>5242375 Figure_3-D</id>
    <infon key="sourcedata_document">2405</infon>
    <infon key="doi">10.15252/embj.201695148</infon>
    <infon key="pmc_id">5242375</infon>
    <infon key="figure">Figure 3-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D</infon>
    <passage>
      <offset>0</offset>
      <text>D An ATP-stabilized complex of p97 containing both UBXD1 and PLAA. Stable HEK293 cell lines were doxycycline-induced to express p97 wild-type (wt) or the ATPase-mutant E578Q (EQ) at near endogenous level. Endogenous UBXD1 was immunoprecipitated and associated proteins detected by immunoblotting with indicated antibodies. Arrowheads indicate endogenous (lower band) and induced p97 (upper band).</text>
    </passage>
  </document>
  <document>
    <id>5242375 Figure_3-E</id>
    <infon key="sourcedata_document">2405</infon>
    <infon key="doi">10.15252/embj.201695148</infon>
    <infon key="pmc_id">5242375</infon>
    <infon key="figure">Figure 3-E</infon>
    <infon key="sourcedata_figure_dir">Figure_3-E</infon>
    <passage>
      <offset>0</offset>
      <text>E Stable HEK293 cells treated as in (D) and transiently expressing GFP-tagged YOD1-wt or the YOD1-C160S catalytic mutant (CS) were processed for co-immunoprecipitation with GFP nanobodies. Asterisk, unspecific band. Note that the YOD1-CS mutant stabilized p97 binding and, in the p97-EQ background, also associated with UBXD1 and PLAA.</text>
    </passage>
  </document>
  <document>
    <id>5242375 Figure_3-F</id>
    <infon key="sourcedata_document">2405</infon>
    <infon key="doi">10.15252/embj.201695148</infon>
    <infon key="pmc_id">5242375</infon>
    <infon key="figure">Figure 3-F</infon>
    <infon key="sourcedata_figure_dir">Figure_3-F</infon>
    <passage>
      <offset>0</offset>
      <text>F Control (IgG) and UBXD1 co-immunoprecipitation with indicated associated proteins from HeLa cells expressing GFP-YOD1-CS after formaldehyde cross-linking. Ufd1 served as a negative control. Scale bars, 10 &#181;m.</text>
    </passage>
  </document>
  <document>
    <id>5242375 Figure_4-A</id>
    <infon key="sourcedata_document">2405</infon>
    <infon key="doi">10.15252/embj.201695148</infon>
    <infon key="pmc_id">5242375</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>A K63- and K48-ubiquitination of damaged lysosomes. Untransfected HeLa cells, or cells expressing mCherry-Gal3 (Ch-Gal3) were LLOMe-treated for 1 h. 2 h after washout, cells were stained with antibodies specific for K63 or K48 chains, and LAMP1 or p62 as indicated. Percentage of K63- or K48-ubiquitinated LAMP1 vesicles and percentage of p62-positive K63 or K48 vesicles were quantified from three independent experiments (mean &#177; SD, Student's unpaired t-test for LAMP1). * = p &lt; 0.05.</text>
    </passage>
  </document>
  <document>
    <id>5242375 Figure_4-B</id>
    <infon key="sourcedata_document">2405</infon>
    <infon key="doi">10.15252/embj.201695148</infon>
    <infon key="pmc_id">5242375</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Colocalization of K63- and K48-linked ubiquitin conjugates on individual lysosomes. Cells expressing GFP-TAB2-NZF (K63-sensor) were treated as in (A) and stained for K48 chains and LAMP1. Note that the apparent nuclear localization of the sensor is a consequence of the extraction procedure (van Wijk et al., 2012).</text>
    </passage>
  </document>
  <document>
    <id>5242375 Figure_4-C-D-E</id>
    <infon key="sourcedata_document">2405</infon>
    <infon key="doi">10.15252/embj.201695148</infon>
    <infon key="pmc_id">5242375</infon>
    <infon key="figure">Figure 4-C-D-E</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>C Cells expressing GFP-p97-EQ were treated as in (A) and stained with antibodies as indicated. D Quantification of the total number of K63- or K48-ubiquitinated vesicles per cell, and number of p97-EQ positive K63- or K48-ubiquitinated vesicles (mean &#177; SD). E Percentage of GFP-p97-EQ vesicles positive for K63 or K48 chains was determined (mean &#177; SD).</text>
    </passage>
  </document>
  <document>
    <id>5242375 Figure_4-F</id>
    <infon key="sourcedata_document">2405</infon>
    <infon key="doi">10.15252/embj.201695148</infon>
    <infon key="pmc_id">5242375</infon>
    <infon key="figure">Figure 4-F</infon>
    <infon key="sourcedata_figure_dir">Figure_4-F</infon>
    <passage>
      <offset>0</offset>
      <text>F ELDR components target K48-conjugates on lysosomes. Detection of GFP-YOD1-CS or UBXD1-GFP alone, or co-transfected with PLAA-HA and GFP-p97-EQ, 2 h after LLOMe washout and co-stained with indicated antibodies.</text>
    </passage>
  </document>
  <document>
    <id>5242375 Figure_5-A-B</id>
    <infon key="sourcedata_document">2405</infon>
    <infon key="doi">10.15252/embj.201695148</infon>
    <infon key="pmc_id">5242375</infon>
    <infon key="figure">Figure 5-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>A Time course of K63- and K48-ubiquitination. Control-depleted cells were fixed at indicated time points after LLOMe washout and stained with chain-specific antibodies and LAMP1. Automated quantification of LAMP1 vesicles positive for K63 or K48 chains. Data represent mean &#177; SD of three independent experiments. B Depletion of p97 or YOD1 results in increase and persistence of K48 chains on damaged lysosomes. Experiment and quantification as in (A) in cells treated with p97 or YOD1 siRNA oligos.</text>
    </passage>
  </document>
  <document>
    <id>5242375 Figure_5-C-D</id>
    <infon key="sourcedata_document">2405</infon>
    <infon key="doi">10.15252/embj.201695148</infon>
    <infon key="pmc_id">5242375</infon>
    <infon key="figure">Figure 5-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>C The p97-EQ mutant stabilizes K48-conjugates. Lysosome damage was induced as in (A) in cells transfected with GFP-tagged p97-wt or p97-EQ. Cells were chased after washout for 12 h and stained for K48 chains. D Quantification of K48-positive lysosomes 2 h and 12 h after damage in cells treated as in (A). Data represent mean &#177; SD of three independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>5242375 Figure_5-E-F</id>
    <infon key="sourcedata_document">2405</infon>
    <infon key="doi">10.15252/embj.201695148</infon>
    <infon key="pmc_id">5242375</infon>
    <infon key="figure">Figure 5-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure_5-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>E The catalytically-inactive mutant of YOD1 stabilizes K48-conjugates. Cells transfected with GFP-tagged YOD1-wt or the YOD1-CS were treated and stained as in (C). F Quantification as in (D) of cells treated as in (E). ** = p &lt; 0.01 *** = p &lt; 0.001 (Student's unpaired t-test). ns, not significant. Scale bars, 10 &#181;m.</text>
    </passage>
  </document>
  <document>
    <id>5242375 Figure_6-A</id>
    <infon key="sourcedata_document">2405</infon>
    <infon key="doi">10.15252/embj.201695148</infon>
    <infon key="pmc_id">5242375</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>A YOD1 can link p97 to ubiquitin. Ubiquitin-GST (Ub-GST) or GST alone was incubated with the indicated purified proteins and isolated. Co-isolated proteins (pulldown) were detected in SDS-gels. Note binding of p97 and YOD1 to Ub-GST only in combination.</text>
    </passage>
  </document>
  <document>
    <id>5242375 Figure_6-B</id>
    <infon key="sourcedata_document">2405</infon>
    <infon key="doi">10.15252/embj.201695148</infon>
    <infon key="pmc_id">5242375</infon>
    <infon key="figure">Figure 6-B</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B</infon>
    <passage>
      <offset>0</offset>
      <text>B The S2 site of YOD1 is critical for ubiquitin binding. Experiments as in (A) with indicated combinations of p97 and YOD1-wt or the ubiquitin-binding mutant, MutS2.</text>
    </passage>
  </document>
  <document>
    <id>5242375 Figure_6-C</id>
    <infon key="sourcedata_document">2405</infon>
    <infon key="doi">10.15252/embj.201695148</infon>
    <infon key="pmc_id">5242375</infon>
    <infon key="figure">Figure 6-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6-C</infon>
    <passage>
      <offset>0</offset>
      <text>C Reconstitution of a complex of ELDR components on ubiquitin. Experiments as in (A) with combinations of p97-wt or p97-EQ, YOD1, PLAA and UBXD1 as indicated. Note that PLAA associates with p97 and YOD1 on ubiquitin only in the case of p97-EQ.</text>
    </passage>
  </document>
  <document>
    <id>5242375 Figure_6-D</id>
    <infon key="sourcedata_document">2405</infon>
    <infon key="doi">10.15252/embj.201695148</infon>
    <infon key="pmc_id">5242375</infon>
    <infon key="figure">Figure 6-D</infon>
    <infon key="sourcedata_figure_dir">Figure_6-D</infon>
    <passage>
      <offset>0</offset>
      <text>D Translocation of YOD1 to lysosomes depends on ubiquitin binding by the S2 site. LLOMe-treated cells expressing GFP-YOD1-CS or the double mutant GFP-YOD1-CS-MutS2 were chased for 2 h and stained for K48 chains and LAMP1. Ratio of GFP signal on K48 vesicles to GFP signal in the whole cell was determined.</text>
    </passage>
  </document>
  <document>
    <id>5242375 Figure_6-E</id>
    <infon key="sourcedata_document">2405</infon>
    <infon key="doi">10.15252/embj.201695148</infon>
    <infon key="pmc_id">5242375</infon>
    <infon key="figure">Figure 6-E</infon>
    <infon key="sourcedata_figure_dir">Figure_6-E</infon>
    <passage>
      <offset>0</offset>
      <text>E The S2 site is essential for K48-conjugate removal. GFP-YOD1-wt or GFP-YOD1-MutS2 overexpressing cells treated as in (D) were stained for K48 chains. Quantification of the number of K48-positive vesicles per cell. Data represent mean &#177; SD of three independent experiments. ** = p &lt; 0.01 (Student's unpaired t-test). Scale bars, 10 &#181;m.</text>
    </passage>
  </document>
  <document>
    <id>5242375 Figure_7-A</id>
    <infon key="sourcedata_document">2405</infon>
    <infon key="doi">10.15252/embj.201695148</infon>
    <infon key="pmc_id">5242375</infon>
    <infon key="figure">Figure 7-A</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Largely mutually exclusive localization of LC3 and K48 chains. GFP-LC3 expressing HeLa cells were fixed 2 h after LLOMe washout and stained for endogenous LAMP1 and K48 or K63 chains. Correlation coefficients were calculated for colocalization of LC3 with K63 or K48. The whiskers represent 10th and 90th percentile. Points below and above the whiskers are drawn as individual dots. The single line indicates the median. *** = p &lt; 0.001 (Mann-Whitney-U test).</text>
    </passage>
  </document>
  <document>
    <id>5242375 Figure_7-B</id>
    <infon key="sourcedata_document">2405</infon>
    <infon key="doi">10.15252/embj.201695148</infon>
    <infon key="pmc_id">5242375</infon>
    <infon key="figure">Figure 7-B</infon>
    <infon key="sourcedata_figure_dir">Figure_7-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Lipofectamine-coated latex beads damage lysosomes and induce their K48-ubiquitination. Cells expressing mCherry-Gal3 were incubated with Lipofectamine-coated latex beads for 3 h and stained with K48 chain-specific antibodies.</text>
    </passage>
  </document>
  <document>
    <id>5242375 Figure_7-C</id>
    <infon key="sourcedata_document">2405</infon>
    <infon key="doi">10.15252/embj.201695148</infon>
    <infon key="pmc_id">5242375</infon>
    <infon key="figure">Figure 7-C</infon>
    <infon key="sourcedata_figure_dir">Figure_7-C</infon>
    <passage>
      <offset>0</offset>
      <text>C YOD1 association and dissociation precedes LC3 recruitment. Live cell video microscopy stills of cells co-expressing mCherry-YOD1-wt and GFP-LC3 after treatment with Lipofectamine-coated latex beads for 30 min at 2 min image intervals.</text>
    </passage>
  </document>
  <document>
    <id>5242375 Figure_7-D</id>
    <infon key="sourcedata_document">2405</infon>
    <infon key="doi">10.15252/embj.201695148</infon>
    <infon key="pmc_id">5242375</infon>
    <infon key="figure">Figure 7-D</infon>
    <infon key="sourcedata_figure_dir">Figure_7-D</infon>
    <passage>
      <offset>0</offset>
      <text>D Stabilization of K48-conjugates on lysosomes impairs recruitment of LC3. Cells expressing GFP-YOD1-CS were treated as in (A) and stained for LAMP1 and p62 or LC3. Percentage of GFP-YOD1 vesicles positive for p62 or LC3 was determined (mean &#177; SD).</text>
    </passage>
  </document>
  <document>
    <id>5242375 Figure_7-E</id>
    <infon key="sourcedata_document">2405</infon>
    <infon key="doi">10.15252/embj.201695148</infon>
    <infon key="pmc_id">5242375</infon>
    <infon key="figure">Figure 7-E</infon>
    <infon key="sourcedata_figure_dir">Figure_7-E</infon>
    <passage>
      <offset>0</offset>
      <text>E Depletion of ELDR components impairs LC3 recruitment for autophagosome formation. Cells were transfected with control (Ctrl), p97 or YOD1 siRNA oligos, treated with LLOMe, fixed after 12 h chase and stained for endogenous LC3 and K48 chains. Quantification of the number of K48-positive vesicles per cell and number of LC3-positive K48 vesicles per cell was determined. Data represent mean &#177; SD of three independent experiments. Scale bars, 10 &#181;m.</text>
    </passage>
  </document>
</collection>
